UnitedHealth Group (NYSE:UNH) Shares Down 8.2% – Should You Sell?

Shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) dropped 8.2% on Wednesday. The company traded as low as $358.32 and last traded at $357.6790. 5,018,678 shares traded hands during mid-day trading, a decline of 30% from the average daily volume of 7,150,820 shares. The stock had previously closed at $389.68.

More UnitedHealth Group News

Investors following UNH have been watching these news items:

  • Positive Sentiment: UnitedHealth raised its 2026 adjusted earnings guidance for the third time this year, to at least $20.50 per share. Higher premiums, benefit reductions and exits from less-profitable markets have helped improve the health insurance operating margin. Article: UnitedHealth Keeps Raising Guidance
  • Neutral Sentiment: A Zacks industry outlook identified UnitedHealth among health-plan companies positioned to benefit from membership trends and healthcare technology, though the coverage is sector-wide rather than company-specific. Article: Zacks Industry Outlook
  • Negative Sentiment: The main near-term concern is a proposed CMS Medicare Advantage audit plan that could recover overpayments dating back to payment year 2018. CMS estimates industry-wide recoveries of about $9 billion per year; UnitedHealth has not disclosed its potential share, leaving uncertainty about the financial impact. Article: UnitedHealth Shares Fall as CMS Proposes Wider Audits

Analyst Ratings Changes

Several equities research analysts have issued reports on UNH shares. Barclays lowered their target price on shares of UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 14th. New Street Research set a $402.00 target price on shares of UnitedHealth Group in a research report on Friday, October 9th. DA Davidson set a $512.00 price target on shares of UnitedHealth Group in a research note on Tuesday, July 21st. UBS Group restated an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, October 13th. Finally, JPMorgan Chase & Co. upped their price objective on shares of UnitedHealth Group from $516.00 to $524.00 and gave the company an “overweight” rating in a research note on Friday, October 16th. Twenty analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $463.93.

Read Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Trading Down 8.9%

The company has a market capitalization of $318.02 billion, a PE ratio of 20.29, a PEG ratio of 1.49 and a beta of 0.51. The company has a fifty day simple moving average of $391.42 and a 200-day simple moving average of $366.73. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping the consensus estimate of $4.14 by $0.55. The business had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company’s quarterly revenue was down .4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Analysts predict that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be paid a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group’s payout ratio is 53.00%.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.19% of the stock is owned by company insiders.

Institutional Trading of UnitedHealth Group

Several institutional investors have recently made changes to their positions in UNH. Nvwm LLC boosted its position in UnitedHealth Group by 89.2% during the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 33 shares during the period. Wellington Altus USA Inc. raised its position in shares of UnitedHealth Group by 97.1% in the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 33 shares during the period. Security National Bank of SO Dak acquired a new stake in shares of UnitedHealth Group in the second quarter worth $29,000. Compass Wealth Management LLC acquired a new stake in shares of UnitedHealth Group in the third quarter worth $29,000. Finally, Aberdeen Wealth Management LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter worth $31,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Read More

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.